Daniel Rotroff

Precision Medicine Researcher, Principal Investigator, Data-Scientist, Views My Own

[Cleveland Clinic @ClevelandClinic]

Your genetics may play a role in how you respond to GLP-1 medications.
Our researchers identified a gene that could help medical providers identify the most effective weight loss interventions for each patient.

[Daniel Rotroff @danielrotroff]

@RomaRajMD did a great job presenting our exciting work demonstrating potential for salivary #biomarkers to detect #liver cancer @AHPBA!

[Roma Raj @RomaRajMD]

Super excited to have presented our work on identifying Salivary and Plasma Metabolites as Biomarkers of HCC at @AHPBA.
Extremely grateful to my mentors @danielrotroff and @FAucejo for this opportunity.
#AHPBA23

[Daniel Rotroff @danielrotroff]

@DrAmandaBrandow Thank you and likewise! I’m looking forward to following along with the exciting developments you and your team are making to predict painful SCD. So important!

[Daniel Rotroff @danielrotroff]

Very honored to receive this award from the NIH HEAL Director! This was a fantastic meeting to see all the innovative research underway to improve #precisionmedicine for those with painful conditions.

[Daniel Rotroff @danielrotroff]

Excited that our paper 'Salivary miRNAs as non-invasive #biomarkers of hepatocellular carcinoma: a pilot study' was one of the top 5 most viewed in its domain on PeerJ in 2022!
https://t.co/hjGQrJA4dy

@mariam_arshiya

[Agrima Mian @AgrimaMianMD]

Pre treatment host metabolome may have biomarker potential in predicting CAR T-cell therapy related toxicities. 🩸Out now @BloodAdvances

One of many novel findings generated at #GuptaLab with exceptional collaborators & mentors @neetuguptaphd @BrianHill_MDPhD @danielrotroff

[Oncology Tube @oncologytube]

Biomarkers: Breast Cancer, SABCS 2022 GENIE Trial - What Will Identifying Genetics and Inflammatory Markers Predict in Chemotherapy-Induced Peripheral Neuropathy? @danielrotroff @CleClinicMD @gt_budd #JosephFossMD

Read and Share the Article Here:
https://t.co/caF2ztlOwG

[Cleveland Clinic Research @CCLRI]

Want to learn more about what our Quantitative Health Science researchers are working on? Hear from @danielrotroff about his recent work on Type 2 diabetes diagnosis 👇

[Shreya Louis MD, MS @ShreyaLouis]

Our study exploring genetic features of seizure freedom following focal epilepsy resections is now published in @FrontNeurol epilepsy section https://t.co/U9Wztl9ie8

#NeurologyTwitter #Epilepsy #MedTwitter @danielrotroff @LaraJehiMD @CharisEngMDPhD

[Daniel Rotroff @danielrotroff]

I’m going to @USAID’s upcoming Space. Will you join too? https://twitterci https://t.co/9XJnT8iD9Y CCF h job him I b he

[npj Digital Medicine @npjDigitalMed]

New #BehindThePaper post from @Hmdjvd and colleagues discussing their work on #deeplearning models for various clinical data collected over time.
https://t.co/8keHxe3H3E

[Daniel Rotroff @danielrotroff]

Excited to share our paper published today @npjDigitalMed! We identified robust #deeplearning approaches for longitudinal clinical data and predicted onset of pediatric #type2diabetes using only BMI history! #Artificial_Intelligence #precisionmedicine #healthcare #diabetes

[npj Digital Medicine @npjDigitalMed]

New! @danielrotroff and colleagues compared nine different deep learning methods to identify two robust approaches for developing predictive models from electronic health records.

https://t.co/53kKYy2at9

[Oncology Tube @oncologytube]

Podcast - Salivary miRNAs As Non-invasive Biomarkers Daniel Rotroff, Ph.D. @danielrotroff @FAucejo @ClevelandClinic #HCC #Biomarkers

Link to Audio:
https://t.co/cNqcwdPIgJ

[Daniel Rotroff @danielrotroff]

I'm honored to be speaking at the ASCPT webinar tomorrow on our recent research identifying type 2 #diabetes subtypes! Sign up at the link below to join!

#Bioinformatics #PrecisionMedicine #pharmacology #Endocrinology #cardiovascular #clinicaltrials

[ASCPT Alexandria @ASCPT_ClinPharm]

Save the date! Thursday August 5 at 1 pm ET: "Taking A Second Look: A Type 2 Diabetes Subtype Responsive to Intensive Glycemia Treatment in the ACCORD Trial." #ASCPTwebinar, #ASCPTPrecisionMedicine, #ASCPTBiomarkers, #ASCPTPGx, #ASCPTInformatics https://t.co/FOhUguVHLh

[Courtney Hershberger @CourtneyHershb2]

Congratulations to @ShreyaLouis (my first friend in the lab) for completing a master's degree in the middle of medical school. We're all so proud of you and grateful for your contributions to the lab!

[Shreya Louis MD, MS @ShreyaLouis]

Successful bioinformatics master's thesis defense ~ I passed! 🎉🍾

Thanks to everyone who came @LaraJehiMD @danielrotroff @CharisEngMDPhD @LodowskiDavid
@KrissieTellez @Neil_Mehta @andrewdhawan @mariam_arshiya @HamedJavidi @CourtneyHershb2 @Vai_DataSci @PinkSachanator

[Daniel Rotroff @danielrotroff]

Many false assertions that drinking alcohol protects or prevents of #COVID19 infection! In a study of ~13k individuals with COVID, we found that frequent/heavy drinkers with #obesity had 2x risk of death. #Genomics #publichealth #alcoholawareness @CCLRI
https://t.co/QAV2dY7tYc

[Daniel Rotroff @danielrotroff]

Paper here: https://t.co/rCDcISaqU7

[Daniel Rotroff @danielrotroff]

Excited to share our new study showing that genetic variability may explain why the ACCORD #T2D trial failed to demonstrate benefit w/ intensive glycemic control. #diabetes #DataScience #PrecisionMedicine #endocrinetwitter @AmDiabetesAssn @mariam_arshiya @mike__kattan

[Cleveland Clinic Research @CCLRI]

New research led by @danielrotroff shows there is a previously unrecognized genetic subtype of patients w/ type 2 #diabetes at high risk for #CVD who may benefit from intensive glycemia treatment, offering new insights into #PrecisionMedicine for #T2D: https://t.co/RElLJF22y9

[Daniel Rotroff @danielrotroff]

@ShreyaLouis @mariam_arshiya It’s so true because everyone talks about wanting to develop/run machine learning pipelines when in reality every case is so different you end up having to massage and tweak it through the entire pipeline...it never just runs. 😂🤣